BPC157CLINIC.COM VOL. I  /  COLOPHON

Vol. I / Colophon / Contact

Contact the Editors

Correspondence on citations, corrections, and research-related inquiries.

References About
Cream paper texture with single ruled line and small ochre stamp
Fig. 7. Plate divider. Correspondence on citations and corrections is welcomed; correspondence on dose, sourcing, or treatment is not.

Editorial correspondence

BPC157clinic.com welcomes correspondence on citations, corrections, and research-related inquiries. The most useful messages are those that flag an inaccurate quotation of a published study, an outdated regulatory reference, or a study omitted from the references page that should be added.

Messages should specify the page of the site they refer to, the passage in question, and the citation (DOI or PMID where possible) supporting the proposed correction.

Editorial mailbox: editors@bpc157clinic.com

Responses are not guaranteed and may be delayed. The editorial mailbox is monitored intermittently.

What we cannot respond to

Caveat. This site is a research-summary publication, not a clinic, not a treatment provider, not a vendor, and not a vendor’s affiliate. We cannot:

  • Recommend or advise on human use of BPC-157.
  • Recommend a dose, schedule, or route of administration for any individual.
  • Diagnose any condition or comment on whether a particular research finding applies to a particular person.
  • Refer to, endorse, or facilitate sourcing of BPC-157 from any vendor.
  • Provide information on compounding pharmacies, given the September 2023 FDA Category 2 listing that excludes BPC-157 from 503A compounding.
  • Respond to inquiries from athletes subject to WADA-code rules regarding any aspect of BPC-157, given its prohibition under section S0.

Readers seeking medical advice should consult a licensed clinician operating within their jurisdiction.

Disclaimer

For research purposes only. Not for human consumption. This site does not sell any product and is not affiliated with any vendor.

Nothing on this site or in any correspondence with the editors constitutes medical advice, diagnosis, treatment recommendation, or an offer to sell any compound or preparation.